Skip to main content

Warnex Concludes $1.7M Acquisition of PRO-DNA Diagnostics

NEW YORK, May 10 (GenomeWeb News) - Warnex, a Quebecois biotechnology company, said yesterday that it has concluded the acquisition of all of the issued and outstanding shares of PRO-DNA Diagnostics.


The company said that it paid CA$1.9 million ($1.7 million) for PRO-DNA, CA$1.4 million of which was paid in cash, and CA$500,000 will become payable either in common shares of Warnex or in cash contingent on milestones
that may be achieved in the 25 months following the closing date of the transaction

Warnex announced its intentions to acquire PRO-DNA, a laboratory that offers genetic testing
services, in April.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.